Phibro Animal Health Corporation (PAHC) - Stock Analysis
Last updated: Apr 25, 2026
Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Phibro Animal Health exhibits strong earnings growth, margin expansion, cash flow strength, and a 42% price surge over the last month, making it a hot short-term idea with a solid fundamental and technical growth profile.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Margin expansion ⢠Strong liquidity ⢠High leverage PAHC's latest quarter shows improving profitability and liquidity with better interest coverage, but high leverage and modest cash conversion remain the main risks.
Price Behavior
Key Price Behavior Insights: ⢠Failed breakout ⢠Near-term support ⢠Mid-range recovery Support Level: $53.80â$54.00 Resistance Level: $59.00â$59.60 PAHC was volatile and range-bound over the last month, with a brief breakout to new highs quickly reversed, leaving the stock near support and best treated as wait-and-see until it either holds $53.80â$54.00 or breaks above $59.00â$59.60.
Sentiment & News
Key News Insights: ⢠Strong earnings momentum ⢠Insider sale signal ⢠Richer valuation scrutiny Phibro Animal Health is seeing strong operational momentum and investor interest, but recent CEO insider sales may raise valuation and ownership questions. #insider-sellingâ
AI Summary
PAHC has moved from a cheap, steady animal-health name to a genuine earnings re-rating story as sales, margins, and guidance all improved together, but with leverage still elevated and free cash flow thin, the stock is now a âprove itâ setup where further upside depends on sustained execution and cleaner cash conversion rather than just past momentum.
Description
Phibro Animal Health Corporation manufactures and sells a range of animal health and mineral nutrition products for livestock, operating through Animal Health, Mineral Nutrition, and Performance Products segments. Its portfolio includes pharmaceutical treatments and vaccines for poultry, swine and cattle, nutritional additives and trace mineral formulations, plus specialty ingredients used in non-food industries. The company distributes products to integrators, feed manufacturers and distributors across North America, Latin America, Europe, the Middle East, Africa and the Asia Pacific from its headquarters in Teaneck, New Jersey.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Sep 2 | Sep 9 | PAHC | Phibro Animal Health Corporation | Phibro Animal Health exhibits strong earnings growth, margin expansion, cash flow strength, and a 42% price surge over the last month, making it a hot short-term idea with a solid fundamental and technical growth profile. | Closed | +12.8% |